Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings worldwide.
See below for updated list of upcoming events.
 |
 DIA (the Drug Information Association), 2017 18 – 22 June, 2017 | Chicago, USA |
Richmond Pharmacology’s Principal Investigators Dr Taubel and Dr Lorch will be presenting at DIA 2017,Chicago
Join our CEO Dr Jorg Taubel, who will be presenting on the topic ‘Combined Adaptive Early Phase Trials: From First-Time-in-Human to Proof of Concept in One Protocol’ Tuesday AM – 20th of June.
Dr Ulrike Lorch will also be in attendance presenting ‘Combined Adaptive Early Phase Trials: From First-Time-in-Human to Proof of Concept in One Protocol’ her presentation will also take place Tuesday AM –20th June.
For more information visit: DIA-2017
I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.
- Anonymous
Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.
- Anonymous
Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.
- Anonymous
Richmond Pharmacology CEO, Dr Jorg Taubel, Franklin Gordon, Resuscitation Simulation & Clinical Skills Practitioner
Read more ›Significant work has been undertaken to push forward the launch of a new apprentice scheme aimed at raising the
Read more ›Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review
Read more ›The Changing Landscape of Early Medicines Development: Be Prepared! Lyon Conference, France, 15-17 May
View event ›
+44 (0) 20 7042 5800
